Serum Uric Acid As a Risk Factor for Cardiovascular and Renal Disease: an Old Controversy Revived

Overview

Journal J Clin Hypertens (Greenwich)

Specialty Cardiology & Vascular Diseases

Date 2006 Jul 20

PMID 16849905

Citations 10

Authors

Francesca Viazzi

Giovanna Leoncini

Elena Ratto

Roberto Pontremoli

Affiliations

Soon will be listed here.

Abstract

Hyperuricemia is commonly associated with traditional risk factors such as abnormalities in glucose metabolism, dyslipidemia, and hypertension. Recent studies have revived the controversy over the role of serum uric acid as an independent prognostic factor for cardiovascular mortality. The authors review clinical and experimental evidence concerning the role of serum uric acid in the development of cardiovascular and renal damage. Results of trials suggesting that serum uric acid variations over time may have a prognostic impact are also discussed.

Citing Articles

Associations between neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, albuminuria and uric acid and the estimated glomerular filtration rate in hypertensive patients with chronic kidney disease stages 1-3.

Sevencan N, Ertinmaz Ozkan A Arch Med Sci. 2019; 15(5):1232-1239.

PMID: 31572468 PMC: 6764306. DOI: 10.5114/aoms.2018.76262.

The effects of topiroxostat on vascular function in patients with hyperuricemia.

Higa S, Shima D, Tomitani N, Fujimoto Y, Kario K J Clin Hypertens (Greenwich). 2019; 21(11):1713-1720.

PMID: 31556223 PMC: 8030428. DOI: 10.1111/jch.13707.

Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid.

Maloberti A, Rebora P, Andreano A, Vallerio P, De Chiara B, Signorini S J Clin Hypertens (Greenwich). 2019; 21(7):975-983.

PMID: 31222917 PMC: 8030372. DOI: 10.1111/jch.13603.

Vascular Aging and Disease of the Large Vessels: Role of Inflammation.

Maloberti A, Vallerio P, Triglione N, Occhi L, Panzeri F, Bassi I High Blood Press Cardiovasc Prev. 2019; 26(3):175-182.

PMID: 31054064 DOI: 10.1007/s40292-019-00318-4.

Uric Acid and Cognitive Function in Older Individuals.

Tana C, Ticinesi A, Prati B, Nouvenne A, Meschi T Nutrients. 2018; 10(8).

PMID: 30060474 PMC: 6115794. DOI: 10.3390/nu10080975.

References

Kang D, Park S, Lee I, Johnson R . Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005; 16(12):3553-62. DOI: 10.1681/ASN.2005050572. View

Rashid M, WILLIAM-OLSSON G . Influence of allopurinol on cardiac complications in open heart operations. Ann Thorac Surg. 1991; 52(1):127-30. DOI: 10.1016/0003-4975(91)91433-v. View

Kanellis J, Watanabe S, Li J, Kang D, Li P, Nakagawa T . Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003; 41(6):1287-93. DOI: 10.1161/01.HYP.0000072820.07472.3B. View

Nicholls A, Snaith M, SCOTT J . Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J. 1973; 1(5851):449-51. PMC: 1588487. DOI: 10.1136/bmj.1.5851.449. View

Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y . Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res. 2005; 27(11):835-41. DOI: 10.1291/hypres.27.835. View

Bickel C, Rupprecht H, Blankenberg S, Rippin G, Hafner G, Daunhauer A . Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol. 2002; 89(1):12-7. DOI: 10.1016/s0002-9149(01)02155-5. View

Tsioufis C, Chatzis D, Vezali E, Dimitriadis K, Antoniadis D, Zervoudaki A . The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage. J Hum Hypertens. 2005; 19(3):211-7. DOI: 10.1038/sj.jhh.1001810. View

Kuzkaya N, Weissmann N, Harrison D, Dikalov S . Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol. 2005; 70(3):343-54. DOI: 10.1016/j.bcp.2005.05.009. View

Hsu S, Pai M, Peng Y, Chiang C, Ho T, Hung K . Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant. 2004; 19(2):457-62. DOI: 10.1093/ndt/gfg563. View

10.

Milionis H, Kakafika A, Tsouli S, Athyros V, Bairaktari E, Seferiadis K . Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004; 148(4):635-40. DOI: 10.1016/j.ahj.2004.04.005. View

11.

Gavin A, Struthers A . Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure. Heart. 2005; 91(6):749-53. PMC: 1768933. DOI: 10.1136/hrt.2004.040477. View

12.

Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E . Serum uric acid and target organ damage in primary hypertension. Hypertension. 2005; 45(5):991-6. DOI: 10.1161/01.HYP.0000161184.10873.ea. View

13.

Athyros V, Elisaf M, Papageorgiou A, Symeonidis A, Pehlivanidis A, Bouloukos V . Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis. 2004; 43(4):589-99. DOI: 10.1053/j.ajkd.2003.12.023. View

14.

Hunsicker L, Adler S, Caggiula A, England B, Greene T, Kusek J . Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997; 51(6):1908-19. DOI: 10.1038/ki.1997.260. View

15.

Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt D, Reaveley D . Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002; 105(22):2619-24. DOI: 10.1161/01.cir.0000017502.58595.ed. View

16.

Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P . Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005; 16(3):791-9. DOI: 10.1681/ASN.2004030208. View

17.

Mazzali M, Kanellis J, Han L, Feng L, Chen Q, Kang D . Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002; 282(6):F991-7. DOI: 10.1152/ajprenal.00283.2001. View

18.

Ito K, Nakashima J, Hanawa Y, Oya M, Ohigashi T, Marumo K . The prediction of renal function 6 years after unilateral nephrectomy using preoperative risk factors. J Urol. 2003; 171(1):120-5. DOI: 10.1097/01.ju.0000100981.11470.2f. View

19.

Watanabe S, Kang D, Feng L, Nakagawa T, Kanellis J, Lan H . Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension. 2002; 40(3):355-60. DOI: 10.1161/01.hyp.0000028589.66335.aa. View

20.

Wong K, MacWalter R, Fraser H, Crombie I, Ogston S, Struthers A . Urate predicts subsequent cardiac death in stroke survivors. Eur Heart J. 2002; 23(10):788-93. DOI: 10.1053/euhj.2001.2970. View